Source: Contract Pharma

Coriolis Pharma: KKR, Flerie Form Specialized Pharma Services Platform with Investment in Coriolis Pharma

To extend Coriolis' position in formulation development and analytical services for innovative high-value biologics, cell and gene therapy products.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Silvia Steyrer-Gruber's photo - CEO of Coriolis Pharma

CEO

Silvia Steyrer-Gruber

CEO Approval Rating

82/100

Read more